Angelini Ventures
Headquarter
Skokie, IL - United States
Milestones
Founded: 2012
Invested: 2023
Founders / CEO
John J. Puisis, CEO
Vertical
Biotech
Board Participation
Paolo di Giorgio, Board Member
Developer of an immune-modifying platform intended to achieve antigen specific tolerance for immune-mediated disease. The company's platform offers non-biological therapeutics for acute inflammation, autoimmunity, and allergic conditions and also engages in pharmaceutical development of immunology, pathology, or cardiovascular medicinal products, enabling patients to get acute treatments for encephalitis syndromes, autoimmune disorders, infections and heart attacks.